Mental Health DailyResearch. Evidence. Perspective.Published research on pregabalin.
A 2026 Taiwanese case series reported VAS pain drops in all 3 adults treated with pregabalin for type I complex regional pain syndrome: 9 to 5, 2 to 1, and 6 to 3 after doses of 75-150 mg/da…
Read articleIt is estimated that 40% of U.S. adults are obese – and this figure is projected to continue growing. One potential reason for weight gain and a possible catalyst for obesity is use of pharm…
Read articleLyrica (pregabalin) and Neurontin (gabapentin) are both classified as “gabapentinoids” (i.e. α2δ ligands). As gabapentinoids, Lyrica (pregabalin) and Neurontin (gabapentin) are chemical anal…
Read articleLyrica (Pregabalin) is a medication approved for the treatment fibromyalgia, neuropathic pain, and partial seizures (as an adjuvant). The drug “pregabalin” was engineered by Pfizer as an imp…
Read articleLyrica (Pregabalin) is a drug that is approved for the treatment of neuropathic pain as well as partial seizures in adults. In some countries (outside the United States) it has also been suc…
Read articleLyrica (Pregabalin) is an anticonvulsant drug utilized primarily to treat neuropathic pain. It is also used as an adjunctive treatment option for adults with partial seizures. In countries o…
Read article
